Related Experiment Video
Updated: Feb 18, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Smoldering myocarditis following immune checkpoint blockade
Timothy G Norwood1, Brian C Westbrook1, Douglas B Johnson2
1UAB School of Medicine, 1670 University Blvd, Birmingham, AL, 35233, USA.
Subclinical myocarditis, a less severe form of immune-related heart inflammation, can occur after immune checkpoint blockade. Early cardiac monitoring and prompt immunosuppression are crucial for managing this condition.
Area of Science:
- Cardiology
- Immunology
- Oncology
Background:
- Severe immune checkpoint blockade-induced myocarditis is known, but less severe forms are poorly understood.
- Most clinical trials lack routine cardiac monitoring, hindering the detection of subclinical myocarditis.
- This study describes a case of subclinical, smoldering myocarditis following combination ipilimumab and nivolumab therapy.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Pericarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

